Status: current, Primitive. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2644761000168119 | magnesium aspartate tetrahydrate (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2644771000168113 | magnesium aspartate tetrahydrate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| magnesium aspartate tetrahydrate | Is a | medicinal substance | true | Inferred relationship | Some | ||
| magnesium aspartate tetrahydrate | is modification of | magnesium | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| zinc amino acid chelate 50 mg (zinc 10 mg) + magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg (total magnesium 52.7 mg) + pyridoxine hydrochloride 4.25 mg capsule | has Australian BoSS | True | magnesium aspartate tetrahydrate | Inferred relationship | Some | 673365749 |
| Zinc Magnesium Performance (Bioglan) (magnesium aspartate tetrahydrate 150 mg + magnesium oxide heavy 70 mg + pyridoxine hydrochloride 4.25 mg + zinc amino acid chelate 50 mg) capsule (trade product unit of use) | has Australian BoSS | True | magnesium aspartate tetrahydrate | Inferred relationship | Some | 460457237 |
This concept is not in any reference sets
FHIR